PRN: 2-Day Data Integrity Seminar: FDA/EMA/TGA Requirements and Implementation Presented by Ex-FDA Director (Sydney, Australia - May 18-19, 2017) - Research and Markets

15/mar/2017 14:30:40 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

2-Day Data Integrity Seminar: FDA/EMA/TGA Requirements and Implementation Presented by Ex-FDA Director (Sydney, Australia - May 18-19, 2017) - Research and Markets


DUBLIN, Mar 15, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Data Integrity: FDA/EMA/TGA Requirements and Implementation: 2-Day In-Person Seminar by Ex-FDA Director" conference to their offering.

Research and Markets Logo

The FDA, EMA, TGA and others have published guidelines setting forth their requirements and expectations for the maintenance of data integrity, as has at least one leading industry organization (PDA).

The use of computer systems in virtually every aspect of data acquisition, storage, and analysis can help preserve data integrity and reduce or eliminate many errors, but the same technology can also create unique problems that must be prevented and managed.

In this two day workshop conference you will learn the meaning of "data integrity"; be exposed to some of the history that influences current regulatory requirements and expectations; see a comparison of the current guidance from leading regulatory agencies including the FDA, EMA, TGA and key industry associations such as the Parenteral Drug Association; see a recap of the enforcement options available to the FDA, including imposition of the Application Integrity Policy (also known as the "Fraud Polic! y"); discuss and learn from selected current real-life case histories; and hear advice for how to prevent, detect and react to data integrity problems so as to minimize business and regulatory risk.

Learning Objectives:

- Understand the meaning of the term data integrity and the importance of the acronym A.L.C.O.A. to regulatory agencies
- Understand the difference between innocent lapses and deliberate wrongful conduct
- Be aware of some of the key historical events that form the basis for regulators' concerns about data integrity
- Understand some of the common motivations for deliberate wrongful conduct that results in data falsification
- Understand the impact of the use of computer systems on the maintenance of data integrity, and what types of system controls are mandated by various agencies around the world
- Be aware of the possible business and regulatory consequences of noncompliance
- Understand the importa! nt steps to take to prevent, detect and react to data integrit! y proble ms

Who Should Attend:

- Senior Quality and Regulatory Affairs managers
- Clinical and Manufacturing Quality professionals
- Regulatory Affairs professionals
- Compliance professionals
- In House Legal Counsel
- Production supervisors
- Manufacturing personnel
- Production personnel
- Laboratory Managers
- Clinical Operations Personnel
- Drug Safety (Pharmacovigilance) Personnel
- R&D and Quality Control Scientists
- Quality auditors

For more information about this conference visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus è un servizio offerto da Factotum Srl